• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

SLC2A1 Gene Record

  • Summary
  • Interactions
  • Claims
  • SLC2A1 6513 Druggable Genome

    Alternate Names:

    6513
    SOLUTE CARRIER FAMILY 2 MEMBER 1
    SLC2A1
    CSE
    DYT17
    DYT18
    DYT9
    EIG12
    GLUT
    GLUT-1
    GLUT1
    GLUT1DS
    HTLVR
    PED
    SDCHCN
    138140
    11005
    ENSG00000117394
    OTTHUMG00000007657
    P11166
    SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER, MEMBER 1 (GLUCOSE TRANSPORTER TYPE 1, ERYTHROCYTE/BRAIN) (HEPG2 GLUCOSE TRANSPORTER). [SOURCE:UNIPROT/SWISSPROT;ACC:P11166]
    Solute carrier family 2, facilitated glucose transporter member 1

    Gene Info:

    Target Class Transporters
    Target Subclass TC:2.A.1.1.28
    Human Readable Name DRUGGABLE GENOME
    Gene Biotype PROTEIN_CODING
    (5 More Sources)

    Gene Categories: Category Details

    TRANSPORTER
    EXTERNAL SIDE OF PLASMA MEMBRANE
    DRUGGABLE GENOME

    Publications:

    Naftalin et al., 2004, Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport., Br. J. Pharmacol.
    Stuart et al., 2007, Overexpression of GLUT5 in diabetic muscle is reversed by pioglitazone., Diabetes Care
    Vera et al., 1996, Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, GLUT1., J. Biol. Chem.
    Hahn et al., 1999, Placental glucose transporter expression is regulated by glucocorticoids., J. Clin. Endocrinol. Metab.
    Shapira R et al., 2013, Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress., J Med Chem
    Medina et al., 2004, Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells., J. Endocrinol.
    Asano et al., 1991, Expression of the GLUT1 glucose transporter increases thymidine uptake in Chinese hamster ovary cells at low glucose concentrations., Cancer Res.
    Wong et al., 2005, The effects of phenytoin and its metabolite 5-(4-hydroxyphenyl)-5-phenylhydantoin on cellular glucose transport., Life Sci.
    Kramer et al., 2001, Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats., Metab. Clin. Exp.
    Dominguez et al., 1996, Studies of renal injury. I. Gentamicin toxicity and expression of basolateral transporters., Am. J. Physiol.
  • THIOCTIC ACID   SLC2A1

    Interaction Score: 11.24

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    23984871


    Sources:
    DTC

  • THYMIDINE   SLC2A1

    Interaction Score: 2.25

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    1868466


    Sources:
    NCI

  • PIOGLITAZONE   SLC2A1

    Interaction Score: 0.75

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    17251278


    Sources:
    NCI

  • GLUFOSFAMIDE   SLC2A1

    Interaction Score: 0.7

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name Glufosfamide
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • GENTAMICIN   SLC2A1

    Interaction Score: 0.54

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    8779884


    Sources:
    NCI

  • ROSIGLITAZONE   SLC2A1

    Interaction Score: 0.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    11699047


    Sources:
    NCI

  • TRIAMCINOLONE   SLC2A1

    Interaction Score: 0.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    10199793


    Sources:
    NCI

  • DIAZEPAM   SLC2A1

    Interaction Score: 0.37

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    15148255


    Sources:
    NCI

  • PHENYTOIN   SLC2A1

    Interaction Score: 0.29

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    15698863


    Sources:
    NCI

  • GENISTEIN   SLC2A1

    Interaction Score: 0.22

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    8621505


    Sources:
    NCI

  • PROGESTERONE   SLC2A1

    Interaction Score: 0.17

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    15350188


    Sources:
    NCI

  • Ensembl: ENSG00000117394

    • Version: 101_38

    Alternate Names:
    SLC2A1 Ensembl Gene Name

    Gene Info:
    Gene Biotype PROTEIN_CODING

    Publications:

  • RussLampel: ENSG00000117394

    • Version: 26-July-2011

    Alternate Names:
    SOLUTE CARRIER FAMILY 2, FACILITATED GLUCOSE TRANSPORTER, MEMBER 1 (GLUCOSE TRANSPORTER TYPE 1, ERYTHROCYTE/BRAIN) (HEPG2 GLUCOSE TRANSPORTER). [SOURCE:UNIPROT/SWISSPROT;ACC:P11166] Description
    SLC2A1 Display Id
    ENSG00000117394 Ensembl Gene Id

    Gene Info:
    Human Readable Name DRUGGABLE GENOME

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • TdgClinicalTrial: P11166

    • Version: January-2014

    Alternate Names:
    SLC2A1 Gene Symbol

    Gene Info:
    Target Class Transporters
    Target Subclass TC:2.A.1.1.28

    Publications:

  • NCI: SLC2A1

    • Version: 14-September-2017

    Alternate Names:

    Gene Info:

    Publications:
    Naftalin et al., 2004, Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport., Br. J. Pharmacol.
    Medina et al., 2004, Differential regulation of glucose transporter expression by estrogen and progesterone in Ishikawa endometrial cancer cells., J. Endocrinol.
    Dominguez et al., 1996, Studies of renal injury. I. Gentamicin toxicity and expression of basolateral transporters., Am. J. Physiol.

  • DTC: SLC2A1

    • Version: 02-September-2020

    Alternate Names:

    Gene Info:

    Publications:
    Shapira R et al., 2013, Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress., J Med Chem

  • HingoraniCasas: ENSG00000117394

    • Version: 31-May-2017

    Alternate Names:
    ENSG00000117394 Gene Symbol
    SLC2A1 Ensembl Id

    Gene Info:

    Gene Categories:
    DRUGGABLE GENOME

    Publications:

  • HumanProteinAtlas: SLC2A1

    • Version: 19.3

    Alternate Names:
    P11166 UniProt ID
    ENSG00000117394 Ensembl Gene ID
    CSE Human Protein Atlas Gene Synonym

    Gene Info:

    Gene Categories:
    TRANSPORTER

    Publications:

  • GO: SLC2A1

    • Version: 01-February-2022

    Alternate Names:
    GLUT1 GO Gene Synonym

    Gene Info:

    Gene Categories:
    EXTERNAL SIDE OF PLASMA MEMBRANE

    Publications:

  • Pharos: SLC2A1

    • Version: 01-February-2022

    Alternate Names:
    Solute carrier family 2, facilitated glucose transporter member 1 Gene Name
    P11166 UniProt ID

    Gene Info:

    Gene Categories:
    TRANSPORTER

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21